Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 26.66 mg (equivalent: nicotine, qty 4 mg) - tablet, uncoated - excipient ingredients: mannitol; sodium carbonate; aspartame; potassium bicarbonate; sodium alginate; xanthan gum; magnesium stearate; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 13.33 mg (equivalent: nicotine, qty 2 mg) - tablet, uncoated - excipient ingredients: mannitol; potassium bicarbonate; aspartame; sodium alginate; sodium carbonate; magnesium stearate; xanthan gum; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine betadex complex, quantity: 17.1 mg (equivalent: nicotine, qty 2 mg) - tablet, uncoated - excipient ingredients: betadex; magnesium stearate; crospovidone; colloidal anhydrous silica - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

wal-mart stores inc - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 21 mg in 24 h - stop smoking aid reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

sam's west inc - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 21 mg in 24 h - stop smoking aid reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

target corporation - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 21 mg in 24 h - stop smoking aid reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

chain drug consortium, llc - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 2 mg - stop smoking aid - reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking - a sodium-restricted diet - heart disease, recent heart attack, or irregular heartbeat. nicotine can increase your heart rate. - high blood pressure not controlled with medication. nicotine can increase blood pressure. - stomach ulcer or diabetes - history of seizures - using a non-nicotine stop smoking drug - taking prescription medicine for depression or asthma. your prescription dose may need to be adjusted.  - mouth, teeth, or jaw problems occur - irregular heartbeat or palpitations occur - you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness, and rapid heartbeat - you have symptoms of an allergic reaction (such as difficulty breathing or rash)

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

dr. reddy's laboratories inc. - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 21 mg in 24 h - stop smoking aid reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 26.66 mg (equivalent: nicotine, qty 4 mg) - tablet, uncoated - excipient ingredients: aspartame; sodium alginate; xanthan gum; potassium bicarbonate; magnesium stearate; sodium carbonate; mannitol; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 13.33 mg (equivalent: nicotine, qty 2 mg) - tablet, uncoated - excipient ingredients: aspartame; xanthan gum; mannitol; sodium alginate; sodium carbonate; magnesium stearate; potassium bicarbonate; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.